IBM artificial intelligence analysis of brain tumor genomes takes only ten minutes

With the continuous advancement of tumor-targeted therapy and personalized therapy, more and more doctors are aware of the importance of genome sequencing of tumors. From the tumor genome analysis, more targeted and more effective targeted treatments can often be found to bring better curative effect to patients. However, quickly finding potential treatment options from large amounts of genomic data is not an easy task, but it is where computer and artificial intelligence programs can make a difference.

Recently, IBM and the New York Genomics Center collaborated to publish a study in which the Watson AI system of IBM obtained the same results as a group of experts by analyzing the genomic data of a brain tumor patient in much less time. The study was published in the recent issue of Neurology Genetics.

IBM人工智能分析脑瘤基因组只需十分钟

IBM Watson analyzed the genomic data of brain tumors. Image source: fiercebiotech

This exploratory study was conducted in a patient with glioblastoma. Glioblastoma is a very dangerous cancer with a high mortality rate and an average survival time of less than 15 months after diagnosis. For such cancer patients, time is extremely valuable, and the sooner a targeted treatment is found, the more likely it is to extend the life of the patient.

As early as 2014, IBM collaborated with the New York Genomics Center to develop a program for analyzing tumor genomes based on IBM's Watson Artificial Intelligence System, called Watson's genome analysis. The team tried the beta version of the program on this patient. It can find targeted treatments for specific genetic changes from more than 27 million biomedical papers.

The researchers obtained a biopsy sample of the tumor and a blood sample from the patient, and sequenced the DNA in the two samples and the RNA in the tumor. For comparison, these sequencing data were sent to the IBM Watson Genome Program and a team of bioinformatics and oncologists for analysis. The Watson system completed a report of clinical treatment options for consideration in just 10 minutes, and the expert analysis took 160 hours to get a similar report. The Watson system has even found more genetic mutations that may be targeted for treatment than the expert group.

IBM人工智能分析脑瘤基因组只需十分钟

Light Amber Halves Walnut Kernels

only divided by color, the quality , the size , the taste are as well as the light halves

different types of the walnut has the different color of the skin of the Walnuts kernels , the little darker color of the light amber color halves is only caused by the different type of the walnuts naturally.

Light Amber Halves Walnut Kernels,Standard Walnut Kernels Light Amber Halves,Walnuts Kernels Light Amber Halves,Light Amber Walnut Kernels Halves

Weishan Yuanxing Walnuts Co.,Ltd. , https://www.walnutsxxy.com